Concepedia

Fidi Koppel

FK

9

Publications

1.2K

Citations

9

H-Index

1992

Active since

Affiliations

Technion – Israel Institute of Technology(Current)

Tel Aviv University

Rabin Medical Center

Rambam Health Care Campus

University of Modena and Reggio Emilia

Fidi Koppel is an author at Technion – Israel Institute of Technology specializing in microbiology, medicine, and clinical microbiology.

Top concepts

Publications per year

1992–2023

9

Publications

9

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 593 citations

, , +9

Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial

Dafna Yahav, Erica Franceschini, Fidi Koppel et al. · Clinical Infectious Diseases · 2018 · 387 citations · Full text

Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes

Amir Nutman, Jonathan Lellouche, Elizabeth Temkin et al. · Clinical Microbiology and Infection · 2020 · 75 citations

, , +11

Duration of antibiotic treatment for Gram-negative bacteremia – Systematic review and individual participant data (IPD) meta-analysis

‪Adi Turjeman‬‏, Elodie von Dach, José Molina et al. · EClinicalMedicine · 2022 · 49 citations · Full text

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

Yaakov Dickstein, Leonard Leibovici, Dafna Yahav et al. · BMJ Open · 2016 · 45 citations · Full text

Rows per page

1–5 of 9